CYBERONICS (NASDAQ:CYBX)

View All ReportsStreetInsider.com Reports on CYBX

Nov 20, 2009 07:19 AM Piper Jaffray Upgrades Cyberonics, Inc. (CYBX) to Overweight

Nov 18, 2009 05:38 PM After-Hours Movers 11/18: DCI, CYBX, LTD Higher; JACK, NMM, AFFY, HOTT, SMTC, MVIS Lower

Nov 18, 2009 05:06 PM Cyberonics (CYBX) Posts Q2 adj.-EPS of $0.32, Tops Street; Boosts FY10 Revenue Guidance

Nov 17, 2009 02:59 PM Trading Radar for 11/18: NetApp (NTAP), Mitsubishi Fiancial (MTU), Chico's FAS (CHS), BJ's Wholesale (BJ), PetSmart (PETM) Report

Oct 2, 2009 09:21 AM Cyberonics (CYBX) Announces Epilepsy Technology Collaborations

View All Press ReleasesCompany Press Releases on CYBX

Nov 20, 2009 09:00AM Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference

Nov 18, 2009 05:00PM Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter

Nov 16, 2009 04:00PM Cyberonics Provides Update on Tax Position

Nov 10, 2009 09:00AM Cyberonics to Host Investor and Analyst Meeting in Boston

Nov 6, 2009 09:00AM Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results

StreetInsider Reports on CYBX by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on CYBX

Oct 11, 2009 03:15 AM M&A Watch: 8 Medical Consumables Companies That Look Like Buyout Targets

Sep 24, 2009 02:24 AM Small Laggards: Suggestions for Chasing the Market

Aug 20, 2009 03:14 PM Cyberonics Inc. F1Q10 (Qtr End 07/24/09) Earnings Call Transcript

May 18, 2009 04:20 AM Smart Money Moves in Q109

Feb 19, 2009 07:43 PM Cyberonics, Inc. F3Q09 (Qtr End 01/23/09) Earnings Call Transcript

View All FilingsSEC Filings on CYBX

Nov 19, 2009 04:32PM Form 10-Q CYBERONICS INC For: Oct 23

Nov 18, 2009 05:03PM Form 8-K CYBERONICS INC For: Nov 18

Nov 10, 2009 03:42PM Form SC 13G CYBERONICS INC Filed by: FMR LLC

Sep 29, 2009 09:59AM Form 8-K CYBERONICS INC For: Sep 29

Comments on recent CYBX articles

Adam Steele
on Jun 14, 2008
at 08:38 PM De novo sales vs. replacement sales Replacement sales increased by 75% in fiscal 2008 over 2007 and were the key driver of growth, masking the mediocre growth of de novo sales. De novo ( new patients) sales are the key measurement of growth and penetration of the epilespy market. I would study, analyze and fully understand slide 11 and go back to the research library. De novo sales were flat year over year. The replacement sale cycle will drop in late fiscal 2009 and the company had better hope that there is a dramatic increase new patient sales.
Article: Canaccord Adams Boosts Price Target On Cyberonics (CYBX) to $28.75, Following Better Results

Comments on CYBX

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?